Regional Business Director (RBD), RayzeBio- Southeast Region
Bristol Myers Squibb
Summary
The Regional Business Director (RBD) - Southeast Region is a sales leader with a mindset of owning the region's business, accountable for demand generation, account engagement, site readiness, and referral performance across RYZ101's regional footprint. The RBD leads a team of 6 to 9 RPT Territory Managers (RTMs), orchestrating across Site Readiness and referral pathways to convert territory-level demand into scheduled, dosed patients.
Job description
Key Responsibilities
Regional Business Ownership
- Own overall regional performance for RYZ101, including demand generation, referral conversion, and dosing volume against regional targets
- Personally own account planning for business-critical accounts within the region, maintaining direct relationships with priority treatment centers rather than delegating solely to RTMs
- Build and continuously refine the regional business plan in partnership with cross-functional teams, adjusting priorities as sites move through licensing, readiness, and activation
- Act as an integral part of the national commercial leadership team, representing regional insights and escalating systemic issues (site operations, referral disruptions, supply) that affect launch execution
Team Leadership
- Direct RTM activity and account coverage decisions in service of regional performance targets
- Hire, coach, and develop a team of 6 to 9 RTMs drawn from a nonstandard talent pool spanning RLT/nuclear medicine and traditional pharma commercial backgrounds
- Set differentiated coaching plans given inconsistent baseline skill sets across the team; run regular pipeline reviews, joint account visits, and account strategy sessions
- Build best in class, diverse teams through structured onboarding, performance management, and succession planning
- Maintain a minimum of 60 to 70 percent of time in the field, including joint calls with RTMs and direct engagement with business critical accounts
Cross-Functional Orchestration
- Partner with Medical Affairs and Market Access peers as a credible commercial counterpart to triage site level bottlenecks escalated by RTMs
- Coordinate with Medical Affairs on referral pathway education and with Sales Operations on shipment timing when either affects a scheduled patient dose
AI and Advanced Analytics Adoption
- Leverage advanced analytics and AI tools to inform coaching, surfacing individual RTM performance patterns and tailoring development plans to each rep's strengths and gaps
- Apply AI-enabled tools to territory and account planning, using data driven insights to prioritize site engagement and referral pathway development
- Champion adoption of new analytics and AI capabilities across the team as they roll out, ensuring RTMs are using available tools consistently rather than defaulting to manual approaches
Requirements
- 7 to 10+ years pharma/biotech commercial leadership
- 3+ years as an RBD, Regional Director, or equivalent regional leadership role
- Proven experience managing a team of 6+ direct reports in a field based commercial role
- Direct launch experience in an access constrained model such as radioligand therapy, CAR-T, gene therapy, or similarly restricted network product
- Track record of cross-functional leadership through influence with Medical Affairs, Market Access, or Sales Operations
- Comfort adopting and championing analytics or AI enabled tools within a field team
- Willingness and ability to maintain a high field presence (60 to 70 percent)
- Prior RBD or equivalent role specifically on RPT (preferred)
- Existing regional relationships within the neuroendocrine tumor or nuclear medicine community (preferred)
- Clinical or technical background that adds credibility in RAM licensing or site readiness conversations (preferred)
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- Retirement Benefits
- Financial Protection Benefits
- Flexible Time Off
- Paid Holidays
- Paid Sick Leave
- Volunteer Days
- Summer Hours Flexibility
- Global Shutdown
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.